Patent · US Active

Melanocortin receptor-specific peptides

US8846601B2 · kind B2 · utility

4Cited by
14References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 2011
Grant dateSep 30, 2014
Priority date
Expiry dateJul 11, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Melanocortin receptor-specific cyclic peptides of the formulawhere R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and z are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.